The content provided is a reference list rather than the main article. Scholarly citations should not be rewritten because changing author names, titles, journals, dates, or DOI information may reduce accuracy and credibility. For SEO, optimize the surrounding heading, introduction, and accessibility attributes while keeping each citation unchanged.
References: MASLD, MASH, Liver Fibrosis and Treatment
This evidence-based reference list includes research on metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, non-invasive diagnostic testing, lifestyle interventions, bariatric surgery, emerging therapies, genetic risk factors and clinical management.
<!-- Keep the original citation text and links unchanged -->
<li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1.">
<p class="c-article-references__text" id="ref-CR1">
Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. <i>Clin. Mol. Hepatol.</i> <b>31</b>, S32–S50 (2025).
</p>
<p class="c-article-references__links u-hide-print">
<a data-track="click_references" rel="nofollow noopener" href="https://doi.org/10.3350%2Fcmh.2024.0431" aria-label="Read Article: Epidemiology of metabolic dysfunction-associated steatotic liver disease" data-doi="10.3350/cmh.2024.0431">Article</a>
<a data-track="click_references" rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=39159948" aria-label="View PubMed record for reference 1">PubMed</a>
<a data-track="click_references" rel="nofollow noopener" href="http://scholar.google.com/scholar_lookup?&title=Epidemiology%20of%20metabolic%20dysfunction-associated%20steatotic%20liver%20disease&journal=Clin.%20Mol.%20Hepatol.&doi=10.3350%2Fcmh.2024.0431&volume=31&pages=S32-S50&publication_year=2025&author=Younossi%2CZM&author=Kalligeros%2CM&author=Henry%2CL" aria-label="Search reference 1 in Google Scholar">Google Scholar</a>
</p>
</li>
<!-- Insert references 2–194 here without changing their bibliographic details -->These references support current understanding of MASLD and MASH epidemiology, diagnosis, fibrosis risk assessment, treatment options and emerging therapeutic approaches. Medical information should be interpreted with guidance from a qualified healthcare professional.
SEO title:
MASLD and MASH References: Diagnosis, Liver Fibrosis and Treatment
Suggested meta description:
Explore research references on MASLD and MASH, including liver fibrosis, non-invasive diagnosis, lifestyle treatment, bariatric surgery, genetics and emerging therapies.
Source: www.nature.com